Victor P. Ghidu, Ph.D.

Victor regularly drafts and prosecutes patent applications in these fields, and counsels clients on a variety of patent life cycle management strategies. He also counsels clients on patent licensing and purchase agreements, as well as agreements relating to product and service supply, collaboration, research, consulting, and material transfer.

Victor brings a wealth of experience to his practice having previously worked as a research scientist in organic and medicinal chemistry, as well as a technical sales specialist at a large multinational specialty chemicals corporation. Victor has co-authored several publications (selected: Ghidu et al., “A new and efficient synthetic route for the anxiolytic agent CL285032” Bioorg. Med. Chem. Lett., 2011, 21(1), 259-261; Ghidu et al., “Combined Chemical and Biosynthetic Route to Access a New Apoptolidin Congener” Org. Lett., 2009, 11 (14), 3032-3034; Ghidu et al., “Synthesis and Evaluation of the Cytotoxicity of Apoptolidinones A and D” J. Org. Chem., 2008, 73 (13), 4949-4955; Pearson and Ghidu, “A New Paradigm for Cationic Cyclization of Iron Tricarbonyl Diene Complexes with Pendant Alkenes and Arenes” Org. Lett., 2002, 4 (23), 4069-4071).

He is credited as a co-inventor on two patent families (WO 2014/150395, granted as US Pat 10,131,637, and WO 2015/054117).